Moleculin Biotech (MBRX) Short Interest
Nasdaq • MBRX • US60855D5077
As of Oct 27, 2026, ORTEX estimated 3.1% of free float sold short, 0.1 days to cover, cost to borrow 180.51%. Sign up for live short interest data.
Nasdaq • MBRX • US60855D5077
As of Oct 27, 2026, ORTEX estimated 3.1% of free float sold short, 0.1 days to cover, cost to borrow 180.51%. Sign up for live short interest data.
This page tracks how heavily Moleculin Biotech (Nasdaq:MBRX) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Moleculin Biotech (Nasdaq: MBRX) has a market capitalization of $7.84M. Last close $8.10 (as of 2026-11-12); 52-week range $3.23 to $253.05. ORTEX data as of 2026-10-27: short interest was 3.14% of free float, 0.1 days to cover and the average cost to borrow was 180.51%. Sign up for live short interest data.